DOI: 10.1097/md.0000000000034784 ISSN:

Soluble suppression of tumorigenicity 2 associated with fulminant myocarditis in children: A retrospective observational study

Wenquan Hou, Tongtong Shi, Yong Li, Wen Li, Menghua Xu, Feng Peng
  • General Medicine

Fulminant myocarditis (FM) is associated with high mortality, and studies on soluble suppression of tumorigenicity 2 (sST2) and myocarditis are still scarce. The aim of this study was to investigate the relationship between sST2 and FM in children with myocarditis. This was a single-center retrospective clinical observational study. We continuously included patients diagnosed as suspected viral myocarditis from December 2019 to December 2022. A total of 203 patients younger than 11 years old were enrolled in this study, 22 of whom were diagnosed with FM. The level of sST2 was positively correlated with N-terminal B-type natriuretic peptide (NT-proBNP) (R = 0.5588, P < .0001). After including multiple factors, creatinine (odd ratio [OR] 0.911; 95% confidence interval [CI], 0.842–0.986; P = .021), NT-proBNP (OR 1.000; 95% CI, 1.000–1.000; P = .01), left ventricular ejection fraction (OR 1.306; 95% CI, 1.153–1.478; P < .001) and sST2 (OR 0.982; 95% CI, 0.965–0.999; P = .038) were still risk factors for FM. The area under curve values were 0.852 for the NT-proBNP, 0.817 for the creatinine, 0.914 for the left ventricular ejection fraction, and 0.865 for the sST2, which showed good sensitivity and specificity for FM. Elevated level of sST2 was associated with fulminant myocarditis. sST2 might be used as a potential biomarker for the diagnosis of fulminant myocarditis.

More from our Archive